Actinium Pharmaceuticals Inc (NY: ATNM )
8.050 -0.140 (-1.71%) Official Closing Price Updated: 6:30 PM EDT, May 30, 2023 Add to My Watchlist
All News about Actinium Pharmaceuticals Inc
(ATNM) - Analyzing Actinium Pharmaceuticals's Short Interest
March 09, 2023
Actinium Announces Positive Full Data Results From the Pivotal Phase 3 SIERRA Trial in Patients with Active, Relapsed or Refractory Acute Myeloid Leukemia
February 22, 2023
– Iomab-B met the primary endpoint of durable Complete Remission (dCR) of 6-months following initial complete remission after BMT with high statistical significance (p-value of <0.0001), 22% of...
With Upcoming Pivotal Data, Analyst Sees 145% Upside In Actinium
September 08, 2022
Benzinga's Top Ratings Upgrades, Downgrades For February 21, 2023
February 21, 2023
Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday
November 23, 2022
Gainers Cosmos Holdings Inc. (NASDAQ: COSM) jumped 86.9% to close at $0.3275 on Tuesday after jumping 21% on Monday. Cosmos Health agreed to sell its Sky Premium Life Luxury food supplement brand on...
Why Dollar Tree Shares Are Trading Lower By 10%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session
November 22, 2022
Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 99.1% to $4.42 after the company announced the FDA granted Fast Track designation to LB1148 for the acceleration of time to return of bowel...
Why Sonnet BioTherapeutics Shares Surged Over 66%; Here Are 63 Biggest Movers From Yesterday
November 01, 2022
Gainers Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) climbed 66.4% to close at $1.93 on Monday after the company announced an agreement with Janssen for the evaluation of three Sonnet product...
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2022
September 08, 2022
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
August 25, 2022
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following